These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3195201)

  • 1. Humoral immune response elicited in rats by measles viral membrane antigens presented in liposomes and ISCOMs.
    Mougin B; Bakouche O; Gerlier D
    Vaccine; 1988 Oct; 6(5):445-9. PubMed ID: 3195201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro cellular immune response to measles viral glycoproteins: role of the antigen vector.
    Bakouche O; Mougin B; Gerlier D
    Immunology; 1987 Dec; 62(4):605-11. PubMed ID: 3428926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses in mice induced by HSV-1 glycoproteins presented with ISCOMs or NISV delivery systems.
    Hassan Y; Brewer JM; Alexander J; Jennings R
    Vaccine; 1996 Dec; 14(17-18):1581-9. PubMed ID: 9032885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presentation of an MuLV-related tumour antigen in liposomes as a potent tertiary immunogen after adoptive transfer.
    Bakouche O; Gerlier D
    Immunology; 1986 Feb; 57(2):219-23. PubMed ID: 3949369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopotentiation of local and systemic humoral immune responses by ISCOMs, liposomes and FCA: role in protection against influenza A in mice.
    Ben Ahmeida ET; Gregoriadis G; Potter CW; Jennings R
    Vaccine; 1993 Oct; 11(13):1302-9. PubMed ID: 8296483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antigenic activity of measles immunostimulating complex].
    Mamaeva TA; Tikhonova NT; Starov AI; Naumova MA; Vysotskiĭ VV
    Vopr Virusol; 1998; 43(3):127-9. PubMed ID: 9702812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against lethal measles virus infection in mice by immune-stimulating complexes containing the hemagglutinin or fusion protein.
    Varsanyi TM; Morein B; Löve A; Norrby E
    J Virol; 1987 Dec; 61(12):3896-901. PubMed ID: 2960833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of infectious bovine rhinotracheitis virus (BHV-1) proteins integrated into ISCOMs or liposomes.
    Franz J; Hampl J; Stĕpánek J; Tesarík R
    Vet Med (Praha); 1996 Jul; 41(7):213-8. PubMed ID: 8774120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles virus fusion protein presented in an immune-stimulating complex (iscom) induces haemolysis-inhibiting and fusion-inhibiting antibodies, virus-specific T cells and protection in mice.
    de Vries P; van Binnendijk RS; van der Marel P; van Wezel AL; Voorma HO; Sundquist B; Uytdehaag FG; Osterhaus AD
    J Gen Virol; 1988 Mar; 69 ( Pt 3)():549-59. PubMed ID: 3258355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of UV-inactivated measles virus.
    Zahorska R; Mazur N; Korbecki M
    Zentralbl Bakteriol Orig A; 1978 Jun; 240(4):424-30. PubMed ID: 696055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canine distemper virus (CDV) immune-stimulating complexes (Iscoms), but not measles virus iscoms, protect dogs against CDV infection.
    De Vries P; Uytdehaag FG; Osterhaus AD
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():2071-83. PubMed ID: 3404123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody responses and protection in mice immunized with herpes simplex virus type 1 antigen immune-stimulating complex preparations.
    Ertürk M; Jennings R; Hockley D; Potter CW
    J Gen Virol; 1989 Aug; 70 ( Pt 8)():2149-55. PubMed ID: 2769234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of antibody response to liposome-associated Gross-virus cell-surface antigen (GCSAa).
    Gerlier D; Sakai F; Doré JF
    Br J Cancer; 1980 Feb; 41(2):236-42. PubMed ID: 7370163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.
    Weijer K; Pfauth A; van Herwijnen R; Jarrett O; Meloen RH; Tomee C; Osterhaus AD
    Vaccine; 1993; 11(9):946-56. PubMed ID: 7692683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant activity of iscoms; effect of ratio and co-incorporation of antigen and adjuvant.
    Bengtsson KL; Sjölander A
    Vaccine; 1996 Jun; 14(8):753-60. PubMed ID: 8817821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomes enhance the immunogenicity of reconstituted influenza virus A/PR/8 envelopes and the formation of protective antibody by influenza virus A/Sichuan/87 (H3N2) surface antigen.
    Gregoriadis G; Tan L; Ben-Ahmeida ET; Jennings R
    Vaccine; 1992; 10(11):747-53. PubMed ID: 1441730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune reactive measles virus polypeptides on the cell's surface: turnover and relationship of the glycoproteins to each other and to HLA determinants.
    Fujinami RS; Sissons JG; Oldstone MB
    J Immunol; 1981 Sep; 127(3):935-40. PubMed ID: 6167634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of individual measles virus structural proteins in the protection of rats from measles encephalitis.
    Brinckmann UG; Bankamp B; Reich A; ter Meulen V; Liebert UG
    J Gen Virol; 1991 Oct; 72 ( Pt 10)():2491-500. PubMed ID: 1833505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo antibody response and in vitro CTL activation induced by selected measles vaccine candidates, prepared with purified Quil A components.
    Stittelaar KJ; Boes J; Kersten GF; Spiekstra A; Mulder PG; de Vries P; Roholl PJ; Dalsgaard K; van den Dobbelsteen G; van Alphen L; Osterhaus AD
    Vaccine; 2000 May; 18(23):2482-93. PubMed ID: 10775782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomes as a tool to study the role of membrane presentation in the immunogenicity of a MuLV-related tumor antigen.
    Gerlier D; Bakouche O; Dore JF
    J Immunol; 1983 Jul; 131(1):485-90. PubMed ID: 6190925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.